Exelixis, Inc.
EXEL
$37.02
$0.371.01%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/17/2025
-
ETF Channel
3/17/2025
-
MarketBeat
3/16/2025
-
MarketBeat
3/15/2025
-
Insider Monkey
3/14/2025
-
MarketBeat
3/13/2025
-
Benzinga
3/13/2025
-
Zacks Investment Research
3/13/2025
-
SeekingAlpha
3/13/2025
-
Ticker Report
3/13/2025
-
The Fly
3/13/2025
-
TipRanks Financial Blog
3/13/2025
-
ETF Channel
3/13/2025
-
MarketBeat
3/12/2025
-
MarketBeat
3/12/2025
-
Ticker Report
3/12/2025
-
Tickeron - Technical Analysis
3/12/2025
-
Ticker Report
3/12/2025
-
MarketBeat
3/11/2025
-
MarketBeat
3/10/2025
-
MarketBeat
3/10/2025
-
MarketBeat
3/9/2025
-
MarketBeat
3/8/2025
-
Tickeron - Stocks
3/8/2025
-
CNW Group - News Releases
3/8/2025
-
PR Newswire
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, February 11, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
End of April (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 837 7000
Address
1851 Harbor Bay Parkway
Alameda, CA 94502
Alameda, CA 94502
Country
Year Founded
Business Description
Sector
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers...
more
